Home LiteratureArticle Details
PMID: 20190816 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells.

Oncogene ·Vol. 29 ·No. 19 ·2010-05-13 ·Pages 2817-30

Schönherr C, Yang HL, Vigny M, Palmer RH, Hallberg B

Abstract

Many different types of cancer originate from aberrant signaling from the anaplastic lymphoma kinase (ALK) receptor tyrosine kinase (RTK), arising through different translocation events and overexpression. Further, activating point mutations in the ALK domain have been recently reported in neuroblastoma. To characterize signaling in the context of the full-length receptor, we have examined whether ALK is able to activate Rap1 and contribute to differentiation/proliferation processes. We show that ALK activates Rap1 via the Rap1-specific guanine-nucleotide exchange factor C3G, which binds in a constitutive complex with CrkL to activated ALK. The activation of the C3G/Rap1 pathway results in neurite outgrowth of PC12 cells, which is inhibited by either overexpression of Rap1GAP or siRNA-mediated knockdown of Rap1 itself or the guanine nucleotide exchange factor C3G. Significantly, this pathway also appears to function in the regulation of proliferation of neuroblastoma cells such as SK-N-SH and SH-SY5Y, because abrogation of Rap1 activity by Rap1-specific siRNA or overexpression of Rap1GAP reduces cellular growth. These results suggest that ALK activation of Rap1 may contribute to cell proliferation and oncogenesis of neuroblastoma driven by gain-of-function mutant ALK receptors.

MeSH Terms
Adaptor Proteins, Signal Transducing/metabolism Anaplastic Lymphoma Kinase Animals Cell Proliferation Cell Transformation, Neoplastic Enzyme Activation/drug effects Extracellular Signal-Regulated MAP Kinases/metabolism GTPase-Activating Proteins/genetics Gene Expression Regulation, Neoplastic Gene Knockdown Techniques Guanine Nucleotide-Releasing Factor 2/deficiency,genetics,metabolism Humans Mice Neurites/metabolism Neuroblastoma/genetics,pathology Nuclear Proteins/metabolism PC12 Cells Protein Kinase Inhibitors/pharmacology Protein-Tyrosine Kinases/antagonists & inhibitors,metabolism Pyrimidines/pharmacology Rats Receptor Protein-Tyrosine Kinases rap1 GTP-Binding Proteins/deficiency,genetics,metabolism
Chemicals
Adaptor Proteins, Signal Transducing CRKL protein GTPase-Activating Proteins Guanine Nucleotide-Releasing Factor 2 NVP-TAE684 Nuclear Proteins Protein Kinase Inhibitors Pyrimidines ALK protein, human Alk protein, mouse Alk protein, rat Anaplastic Lymphoma Kinase Protein-Tyrosine Kinases Receptor Protein-Tyrosine Kinases Extracellular Signal-Regulated MAP Kinases rap1 GTP-Binding Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Schönherr C
Department of Molecular Biology, Umeå University, Umeå, Sweden.
Yang H-L
Vigny M
Palmer R H
Hallberg B
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
1476-5594
Published
2010-05-13
Epub
2010-00-01
Pages
2817-30
Language
English
Region
England
NLM ID
8711562
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com